CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases

Biocon  /  News – Posts  /  Press Releases

Anekal Education Summit 2025 to Chart Vision 2030 to Fulfill Classroom Dreams of Students

  • Posted by: BIOCON

Biocon Biologics’ Yesafili® (aflibercept) Now Publicly Funded in Ontario, Canada for the Advanced Treatment of Patients with Retinal Diseases

  • Posted by: BIOCON

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars

  • Posted by: BIOCON

Biocon Foundation Supports Government High School, Kicks off Construction of a New Building for 250 Students

  • Posted by: BIOCON

Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey

  • Posted by: BIOCON

Biocon Q1FY26 Operating Revenue at Rs 3,942 Cr, Up 15% EBITDA at Rs 829 Cr; Up 19%*;

  • Posted by: BIOCON

Biocon Foundation and IISc Commemorate World Head & Neck Cancer Day

  • Posted by: BIOCON

Deepali Naair Appointed as the Global Head – Brand & Corporate Communications at Biocon Biologics

  • Posted by: BIOCON

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

  • Posted by: BIOCON

Advancing Bone Health: European Commission Approves Biocon Biologics’ Denosumab Biosimilars

  • Posted by: BIOCON
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>